Zoetis (ZTS) news
Recent news
Zoetis rises on emergency use authorization for screwworm drug
Zoetis Inc. (ZTS) shares rose following the U.S. Food and Drug Administration’s (FDA) issuance of an emergency use authorization for a drug targeting the New World screwworm, a parasitic threat to livestock. The authorization, announced recently, allows for use of the animal drug to address an…
AInvest Wire · Aug 13, 2026Zoetis Inc: BNP Paribas cuts target price to $110 from $146
BNP Paribas has revised its price target for Zoetis Inc. (NYSE: ZTS) to $110 from $146, while maintaining an "outperform" rating for the stock. The adjustment reflects the bank’s updated assessment of the animal health company’s outlook and market positioning. Zoetis currently trades at $72.57,…
AInvest Wire · Aug 11, 2026Citigroup cuts target price to $96 from $112 for Zoetis Inc
Citigroup Inc. has revised its price target for Zoetis Inc. (ZTS), lowering it to $96 from a previous $112, while maintaining a "Buy" rating . This adjustment reflects a broader recalibration of analyst expectations following Zoetis’ Q1 2026 earnings report, which revealed weaker-than-expected…
AInvest Wire · Aug 11, 2026Zoetis Inc.: Morgan Stanley cuts target price to $85.00 from $99.00
AInvest Wire · Aug 7, 2026Zoetis exec says company is using rebates and other targeted investments instead of cutting list prices - conf call
AInvest Wire · Aug 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.